Association of Myosin Light Chain 2 (MLC 2) with Troponin-I and Ejection Fraction in patients with Acute Coronary Syndrome

Authors

  • Samira Anwar Dept. of Immunology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM),Dhaka
  • Mansura Khan Assistant Professor, Dept. of Immunology, BIRDEM, Dhaka
  • Ashesh Kumar Chowdhury Professor, Department of Immunology, BIRDEM, Dhaka

DOI:

https://doi.org/10.3329/bccj.v5i1.32541

Keywords:

ACS, MLC2, Troponin I, Ejection fraction

Abstract

Background: Acute coronary syndrome (ACS) is a major health problem and represents a large number of hospitalizations annually. Myosin light chain (MLC2)isasensitive early marker (within four hours) of ACS that can be used to confirm or exclude a diagnosis of acute cardiac condition. The present study was undertaken for rapid diagnosis ACS with the help of elevated MLC-2and its relation with Troponin I and ventricular ejection fraction.

Method: In this cross sectional study,60 patients ofACS were enrolled from coronary care unit (CCU), BIRDEM as case and 25 apparently healthy people from cardiac point of view as control. Selection of patients was done according to the inclusion and exclusion criteria.MLC-2was measured(within 3-4 hours by ELISA method and level of ventricular dysfunction and troponin I (in ACS group) was taken from hospital records.

Results: The mean ± SEM of MLC-2 was higher in the ACS group (88.02±18.0 pgm/ml) compared to the healthy control group (41.4±2.2 pgm/ml) and difference was statistically significant (p<0.05). The inverse correlation between MCL-2 and ejection fraction was highly significant (r=-0.647, p=0.001). The correlation with MLC-2 and troponin I was also significant (r=0.831, p=0.01).

Conclusion: Statistically significantMLC2level was found in the ACS group than the healthy control group. Positive correlation was also observed between MLC-2 with Troponin I and ventricular dysfunction. Therefore, MLC 2 may be used as a biomarker early diagnosis of ACS.

Bangladesh Crit Care J March 2017; 5(1): 37-41

Downloads

Download data is not yet available.
Abstract
659
PDF
724

Author Biography

Samira Anwar, Dept. of Immunology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM),Dhaka



Downloads

Published

2017-05-11

How to Cite

Anwar, S., Khan, M., & Chowdhury, A. K. (2017). Association of Myosin Light Chain 2 (MLC 2) with Troponin-I and Ejection Fraction in patients with Acute Coronary Syndrome. Bangladesh Critical Care Journal, 5(1), 37–41. https://doi.org/10.3329/bccj.v5i1.32541

Issue

Vol. 5 No. 1 (2017)

Section

Original Articles

License

Upon acceptance for publication the copyright of the paper automatically transfers to the BCCJ and will not be published elsewhere either in part or whole without written permission of the copyright holder.

Except for personal use, no part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, photocopying, recording or otherwise without the prior written permission of the publisher.